Healthcare Triangle (Nasdaq: HCTI) Successfully Completes Share Issuances Linked to Legacy M&A Deals, Strengthening Nasdaq Compliance
Pleasanton, Calif. – July 29, 2026: Healthcare Triangle, Inc. (Nasdaq: HCTI), a prominent provider of digital transformation, artificial intelligence, and cloud infrastructure solutions for healthcare and life sciences, has announced the completion of significant share issuances related to two previously approved transactions. These actions are aimed at ensuring the company’s continued compliance with Nasdaq’s newly introduced minimum Market Value of Listed Securities (MVLS) standard.
Key Developments Investors Must Know
- Major Share Issuance: On July 24, 2026, Healthcare Triangle issued a total of 12,546,540 shares of common stock in connection with the closing of the acquisition of Teyame AI LLC and related parties (the “Teyame Transaction”), as well as a Share Exchange Agreement with SecureKloud Technologies Ltd.
- Common Shares Outstanding: After these issuances, the total common shares outstanding as of July 28, 2026, stands at 14,644,322 shares.
- Nasdaq Compliance – MVLS Rule: The U.S. Securities and Exchange Commission recently approved a new Nasdaq listing requirement, effective July 22, 2026, mandating a minimum MVLS of \$5 million for all listed companies. Healthcare Triangle’s share issuances have significantly improved its compliance position.
- Market Value Calculation: As of July 28, 2026, Healthcare Triangle’s MVLS was approximately \$23,824,244, calculated based on a closing share price of \$1.63. This figure provides a substantial buffer above the new \$5 million threshold.
- Price Sensitivity: The increased share count and MVLS position are potentially price-sensitive, as they directly impact the company’s eligibility to remain listed on Nasdaq. Shareholders should monitor future fluctuations in share price and outstanding shares, as Nasdaq compliance is determined by ongoing closing bid prices and listed shares.
- Growth Strategy & Management Statement: David Ayanoglou, Chief Financial Officer of Healthcare Triangle, emphasized that completing these legacy transactions is a vital step in the company’s growth strategy. He noted the strengthened compliance position under Nasdaq’s new standard, which provides added confidence for shareholders regarding continued listing on the Nasdaq Global Market.
Company Overview
Healthcare Triangle delivers advanced digital transformation, artificial intelligence, and cloud infrastructure solutions to healthcare providers, payers, and life sciences organizations. The company is committed to enhancing healthcare delivery through improved security, compliance, data analytics, and operational efficiency.
Forward-Looking Statements and Risks
This announcement contains forward-looking statements regarding Healthcare Triangle’s MVLS, Nasdaq listing compliance, and the effects of its recent transactions. These statements are subject to risks including share price volatility, changes in shares outstanding, and Nasdaq’s application of listing standards. Actual results may differ materially from current expectations. Investors are encouraged to review Healthcare Triangle’s Annual Report on Form 10-K and other SEC filings for a detailed discussion of risks.
Investor Contact
Healthcare Triangle, Inc. (Nasdaq: HCTI)
1-800-617-9550
[email protected]
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a solicitation to buy or sell securities. All forward-looking statements are subject to risks and uncertainties. Investors should conduct their own due diligence and consult with financial advisors before making investment decisions.
